Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Net Income towards Common Stockholders Growth (3y) (2025 - 2026)

Analysis

Bioregenx (BRGX) Net Income towards Common Stockholders Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 24.56%
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 22.97%
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 20.02%
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 51.47%
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn -7.83%
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn 29.05%
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn 18.63%
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn -
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 17.97%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 17.97%
Dec 31, 2025 -221.83%
Sep 30, 2025 -232.53%
Jun 30, 2025 -75.02%
Mar 31, 2025 -92.66%
API Access

Bioregenx Net Income towards Common Stockholders Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders-growth-3y&ticker=BRGX&period=max&api_key=YOUR_API_KEY